Connective tissue growth factor was found to be overexpressed in mammary tumours, pancreatic cancer, sarcoma cancers, prostate cancers (Yang et al, 2005) and gliomas (Yin et al, 2010). The gene discussed is CCN2; the disease is prostate cancer.